Chlordiazepoxide antinociception: cross-tolerance with opiates and with stress.
Chlordiazepoxide (CDP) has been previously shown to possess antinociceptive properties that are resistant, except at high doses, to the opiate antagonist naloxone. The present study evaluated whether CDP's antinociceptive effects were subject to tolerance following repeated injections and whether cross-tolerance might develop between the antinociceptive action of CDP and that of either morphine or cold water swins. CDP increased flinch-jump thresholds following acute administration and exhibited tolerance following repeated injections. Neither morphine-tolerant nor cold water swim-adapted rats displayed an antinociceptive effect when tested with CDP. On the other hand, chronic pretreatment with CDP attenuated the antinociceptive effects of cold water swims, but did not produce any clear effect upon morphine analgesia.
D000700:Analgesics; D000818:Animals; D002707:Chlordiazepoxide / Q000494:pharmacology*; D003080:Cold Temperature; D004361:Drug Tolerance; D009020:Morphine / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology*; D051381:Rats; D013312:Stress, Physiological / Q000523:psychology*; D013550:Swimming
D000700:Analgesics; D009294:Narcotics; D002707:Chlordiazepoxide; D009020:Morphine